Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)

Next Previous
Trial Profile

Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 14 Aug 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Antithrombin alfa (Primary)
  • Indications Preeclampsia
  • Focus Registrational; Therapeutic Use
  • Acronyms PRESERVE-1
  • Sponsors rEVO Biologics

Most Recent Events

  • 08 Aug 2020 Primary endpoint (The primary outcome measure is the increase in gestational age) has not been met according to the results published in the American Journal of Obstetrics and Gynecology
  • 08 Aug 2020 Results published in the American Journal of Obstetrics and Gynecology
  • 07 Feb 2017 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top